US 7250414
Diphenylmethyl compounds useful as muscarinic receptor antagonists
granted A61PA61P11/00A61P11/06
Quick answer
US patent 7250414 (Diphenylmethyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jul 31 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P43/00, A61P9/00